Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Hemolysis Detection Devices Market Size, Value And Growth Trajectory Through 2030
The hemolysis detection devices market size has experienced significant growth in recent years. It is projected to expand from $0.92 billion in 2025 to $0.99 billion in 2026, at a compound annual growth rate (CAGR) of 7.5%. The market’s historical growth can be linked to factors such as the increasing prevalence of hemolytic disorders, a rise in blood transfusion procedures, growing volumes of clinical laboratory testing, the adoption of spectrophotometry in diagnostics, and an increased regulatory focus on sample quality standards.
The hemolysis detection devices market is anticipated to experience substantial expansion over the upcoming years, reaching a valuation of $1.34 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.7%. This projected increase during the forecast period is due to factors such as the increasing need for automated laboratory processes, greater investment in advanced diagnostic infrastructure, the growing use of portable point-of-care devices, the widening reach of blood bank networks in developing regions, and a heightened focus on the early identification of complications associated with transfusions. Key developments expected during this period involve the increasing uptake of automated hemolysis detection systems, a rising demand for high-throughput laboratory analyzers, the expanding integration of spectrophotometric detection technologies, the growth of point-of-care hemolysis testing, and an elevated emphasis on protocols for blood sample quality control.
Get A Free Sample Report With In-Depth Market Insights:
Hemolysis Detection Devices Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The expanding clinical trials activity is anticipated to drive the advancement of the hemolysis detection devices market in the future. Clinical trials encompass research studies conducted on human subjects to evaluate the safety and effectiveness of new drugs or treatments, where headspace gas analysis plays a role in maintaining product quality and stability throughout these studies. The increase in clinical trial activity is attributed to a rising demand for innovative and effective therapies, fueled by the growing prevalence of chronic and lifestyle diseases, which necessitate more extensive clinical studies to safely assess new treatments. Hemolysis detection devices support clinical trial activity by quickly identifying the breakdown of red blood cells in blood samples, thereby ensuring sample integrity and dependable laboratory results, both crucial for accurate assessment of drug safety and efficacy. For instance, in December 2024, data from the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, showed that the number of industry clinical trials initiated in the UK climbed to 426 in 2023, up from 411 in 2022. Consequently, the escalating clinical trials activity is propelling the growth of the hemolysis detection devices market.
Hemolysis Detection Devices Market Segment Trends And Revenue Contributors
The hemolysis detection devices market covered in this report is segmented –
1) By Product Type: Benchtop Hemolysis Detection Devices, Portable Hemolysis Detection Devices, Automated Hemolysis Detection Systems
2) By Technology: Spectrophotometry, Colorimetry, Visual Inspection, Other Technologies
3) By Application: Blood Banks, Hospitals, Diagnostic Laboratories, Research Institutes, Other Applications
4) By End-User: Hospitals And Clinics, Blood Centers, Research And Academic Institutes, Other End Users
Subsegments:
1) By Benchtop Hemolysis Detection Devices: Single Sample Benchtop Hemolysis Analyzers, Multi Sample Benchtop Hemolysis Analyzers, Integrated Laboratory Benchtop Hemolysis Systems
2) By Portable Hemolysis Detection Devices: Handheld Hemolysis Detection Devices, Battery Operated Portable Hemolysis Analyzers, Point Of Care Portable Hemolysis Devices
3) By Automated Hemolysis Detection Systems: Fully Automated Hemolysis Detection Systems, Semi Automated Hemolysis Detection Systems, High Throughput Automated Hemolysis Analyzers
Hemolysis Detection Devices Market Innovation Trends Shaping Future Development
Key players in the hemolysis detection devices market are concentrating on creating advanced products like point-of-care blood gas analyzers equipped with hemolysis detection. This aims to facilitate swift, precise, and bedside identification of hemolysis, thereby enhancing clinical decision-making and patient outcomes. Such a point-of-care blood gas analyzer, featuring hemolysis detection capabilities, functions as a portable diagnostic system that evaluates crucial blood parameters directly at the patient’s bedside and simultaneously identifies sample hemolysis, contributing to prompt and dependable clinical choices by boosting test accuracy and reducing inaccuracies caused by red blood cell degradation. For example, in July 2024, Werfen S.A., a diagnostics firm based in Spain, launched its GEM Premier 7000 incorporating intelligent quality management 3 (iQM3). This device was developed to tackle significant difficulties encountered in point-of-care blood gas analysis. The system integrates patented acoustofluidic technology with photometric determination, allowing it to detect hemolysis within 45 seconds, thereby guaranteeing precise measurements of potassium and other blood gases. Furthermore, the system includes automated, real-time quality controls for hemolysis, micro-clots, bubbles, and lipemia. It also offers an extensive test menu covering pH, electrolytes, and CO-oximetry, positioning it as an optimal solution for improving patient safety, supporting clinical decision-making, and streamlining workflow efficiency in critical care environments.
Hemolysis Detection Devices Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the hemolysis detection devices market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson Company, Mindray Bio Medical Electronics Co. Ltd., Sysmex Corporation, Bio Rad Laboratories Inc., Werfen S.A., HORIBA Medical SAS, Greiner Bio One International GmbH, Randox Laboratories Ltd., Agappe Diagnostics Ltd., Guangzhou Wondfo Biotech Co. Ltd., Radiometer Medical ApS, EKF Diagnostics Holdings plc, Hemcheck Sweden AB, Alta DiagnoTech Co. Ltd., Ortho Clinical Diagnostics Inc.
View The Full Hemolysis Detection Devices Market Report:
Hemolysis Detection Devices Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the hemolysis detection devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemolysis detection devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
